Trial Profile
Occurrence of Brain Metastasis in Breast Cancer Patients Diagnosed at Advanced Stages of the Disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Sep 2023
Price :
$35
*
At a glance
- Drugs Lapatinib (Primary) ; Trastuzumab (Primary)
- Indications Advanced breast cancer; Cancer metastases
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 23 May 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 09 May 2013 Planned end date changed from 1 Aug 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 23 Apr 2012 Planned End Date changed from 1 Feb 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.